Tech Johnson & Johnson will buy cardiovascular technology company Abiomed in $16.6 billion deal Jonathan Jeriah November 16, 2022 1 min read Johnson & Johnson will buy cardiovascular technology company Abiomed in $16.6 billion deal.Read More About The Author Jonathan Jeriah See author's posts Continue Reading Previous Previous post: ‘We’ve slotted him everywhere else and it hasn’t worked’: Why Huberdeau is on Flames 3rd lineNext Next post: Badenoch Calls for Green Investment to ‘Future-Proof’ UK Economy Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Related News New blood tests for multiple cancers gain political backing New blood tests for multiple cancers gain political backing December 23, 2025 Boutique & Luxury Lodging Association (BLLA) Partners With AI Crash Course to Advance AI Literacy Across Independent Hospitality Boutique & Luxury Lodging Association (BLLA) Partners With AI Crash Course to Advance AI Literacy Across Independent Hospitality December 23, 2025